摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,6S,8aR)-6-(N,N-dibenzylamino)-1-octahydroindolizinol | 159498-00-7

中文名称
——
中文别名
——
英文名称
(1R,6S,8aR)-6-(N,N-dibenzylamino)-1-octahydroindolizinol
英文别名
(1R,6S,8aR)-6-(dibenzylamino)-1,2,3,5,6,7,8,8a-octahydroindolizin-1-ol
(1R,6S,8aR)-6-(N,N-dibenzylamino)-1-octahydroindolizinol化学式
CAS
159498-00-7
化学式
C22H28N2O
mdl
——
分子量
336.477
InChiKey
JXXIYVYDDPXBIP-BHDDXSALSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    26.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1R,6S,8aR)-6-(N,N-dibenzylamino)-1-octahydroindolizinolpalladium dihydroxide 氢气 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 170.0h, 生成 (-)-1,8a-Diepislaframine
    参考文献:
    名称:
    Enantiomerically Pure Amino Alcohols and Diamino Alcohols from L-Aspartic Acid. Application to the Synthesis of Epi- and Diepislaframine
    摘要:
    Starting from natural aspartic acid (6) a practical method for the synthesis of enantiomerically pure 3-amino alcohols 8 including 3,4-diamino derivatives is described. After perbenzylation of 6 and reduction of both carboxylates, position 4 of the resultant (dibenzylamino)butanediol (11) could be regioselectively blocked to afford the silyloxy-protected intermediate 12a. Functionalization of position 1 was accomplished by nucleophilic displacement reactions including a 2-fold migration of the dibenzylamino substituent or by reductive amination of the amino aldehyde 15. Both routes proceeded under complete preservation of the optical purity. For envisioned SAR studies, we, furthermore, report on the application of this method to a chirospecific synthesis of epi- and diepislaframine (9a and 9b) as diastereomers of the highly bioactive indolizidine alkaloid slaframine (9c). Our first approach including reductive coupling of the chiral amino aldehyde 15 with 5-hydroxypyrrolidine failed when formation of a quaternary ammonium salt occurred, preventing the anticipated anionic cyclization. Therefore, we turned out attention to methodology developed by Wasserman. In fact, introduction of a 3-hydroxypyrrole-2-carboxylate fragment gave a cyclization precursor (30b) which could be successfully transformed into epi- and diepislaframine.
    DOI:
    10.1021/jo00101a042
  • 作为产物:
    描述:
    tert-butyl (6S)-6-(N,N-dibenzylamino)-2,3,5,6,7,8-hexahydro-1-oxo-8a(1H)-indolizinecarboxylate 在 sodium tetrahydroborate 、 三氟乙酸 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 4.0h, 生成 (1R,6S,8aR)-6-(N,N-dibenzylamino)-1-octahydroindolizinol
    参考文献:
    名称:
    Enantiomerically Pure Amino Alcohols and Diamino Alcohols from L-Aspartic Acid. Application to the Synthesis of Epi- and Diepislaframine
    摘要:
    Starting from natural aspartic acid (6) a practical method for the synthesis of enantiomerically pure 3-amino alcohols 8 including 3,4-diamino derivatives is described. After perbenzylation of 6 and reduction of both carboxylates, position 4 of the resultant (dibenzylamino)butanediol (11) could be regioselectively blocked to afford the silyloxy-protected intermediate 12a. Functionalization of position 1 was accomplished by nucleophilic displacement reactions including a 2-fold migration of the dibenzylamino substituent or by reductive amination of the amino aldehyde 15. Both routes proceeded under complete preservation of the optical purity. For envisioned SAR studies, we, furthermore, report on the application of this method to a chirospecific synthesis of epi- and diepislaframine (9a and 9b) as diastereomers of the highly bioactive indolizidine alkaloid slaframine (9c). Our first approach including reductive coupling of the chiral amino aldehyde 15 with 5-hydroxypyrrolidine failed when formation of a quaternary ammonium salt occurred, preventing the anticipated anionic cyclization. Therefore, we turned out attention to methodology developed by Wasserman. In fact, introduction of a 3-hydroxypyrrole-2-carboxylate fragment gave a cyclization precursor (30b) which could be successfully transformed into epi- and diepislaframine.
    DOI:
    10.1021/jo00101a042
点击查看最新优质反应信息

文献信息

  • Enantiomerically Pure Amino Alcohols and Diamino Alcohols from L-Aspartic Acid. Application to the Synthesis of Epi- and Diepislaframine
    作者:Peter Gmeiner、Dagmar Junge、Annerose Kaertner
    DOI:10.1021/jo00101a042
    日期:1994.11
    Starting from natural aspartic acid (6) a practical method for the synthesis of enantiomerically pure 3-amino alcohols 8 including 3,4-diamino derivatives is described. After perbenzylation of 6 and reduction of both carboxylates, position 4 of the resultant (dibenzylamino)butanediol (11) could be regioselectively blocked to afford the silyloxy-protected intermediate 12a. Functionalization of position 1 was accomplished by nucleophilic displacement reactions including a 2-fold migration of the dibenzylamino substituent or by reductive amination of the amino aldehyde 15. Both routes proceeded under complete preservation of the optical purity. For envisioned SAR studies, we, furthermore, report on the application of this method to a chirospecific synthesis of epi- and diepislaframine (9a and 9b) as diastereomers of the highly bioactive indolizidine alkaloid slaframine (9c). Our first approach including reductive coupling of the chiral amino aldehyde 15 with 5-hydroxypyrrolidine failed when formation of a quaternary ammonium salt occurred, preventing the anticipated anionic cyclization. Therefore, we turned out attention to methodology developed by Wasserman. In fact, introduction of a 3-hydroxypyrrole-2-carboxylate fragment gave a cyclization precursor (30b) which could be successfully transformed into epi- and diepislaframine.
查看更多

同类化合物

长春内日啶 钩藤碱e 钩藤碱d 钩藤碱A 钩藤碱 C 钩藤碱 虎皮楠生物碱B 甲基二氯镓 流涎胺 栗精胺 柯诺辛B 柯诺辛 恩卡林碱 F 异钩藤碱 异帽叶碱 异去氢钩藤碱 帽柱叶碱 四氢-吲哚嗪-1,3-二酮 去氢钩藤碱 卡拉巴宾 六氢吲嗪-8-酮 六氢吲哚嗪-3,7-二酮 六氢-5(1H)-吲嗪硫酮 六氢-3(2H)-吲嗪硫酮 八氢吲嗪 八氢-6,7-吲嗪二醇 八倾吲嗪三醇 二环[2.2.1]庚烷-2-醇,3-(二甲氨基)-,[1S-(内,内)]-(9CI) 丙酸,2,2-二甲基-,八氢-7,8-二羟基-1,6-中氮茚二基酯,1S-(1.α.,6.β.,7.α.,8.β.,8a.β.)- 一叶萩碱 一叶秋碱 α.-塔洛-九吡喃糖,1,6:2,3-二脱水-4,7,8,9-四脱氧- [(1S,6S,7S,8R,8aR)-1,7,8-三羟基-1,2,3,5,6,7,8,8a-八氢吲嗪-6-基] 丁酸酯 N-[(1S,6S,7R,8R,8aR)-1,7,8-三羟基辛氢-6-吲哚嗪基]乙酰胺 8a-乙炔基-2,3,5,6,7,8-六氢-1H-吲嗪 8-氨基-3-氧代八氢-1-吲嗪羧酸 8-中氮茚醇,八氢-1,6,7-三(苯基甲氧基)-,1S-(1.α.,6.β.,7.α.,8.β.,8a.β.)- 6,7-二羟基苦马豆素 5(1H)-中氮茚酮,六氢-,(R)- 4-氨基-1H-苯并咪唑-6-羧酸 2-甲基-5-氧代八氢-3-吲嗪甲醛 1-甲基八氢-1-吲哚嗪并l 1,7,8-中氮茚三醇,八氢-6-(1-甲基丙基)氨基- 1,6,7-中氮茚三醇,八氢-8-甲氧基-,1S-(1.α.,6.β.,7.α.,8.β.,8a.β.)- 1,2-异亚丙基苦马豆素 (八氢吲哚啉-8-基)-甲醇 (R)-12-羟基十八烷酸 (8aS)-六氢-5,8-吲嗪二酮 (6S,7R,8R,8aR)-1,2,3,5,6,7,8,8a-八氢吲嗪-6,7,8-三醇 (6R,8AS)-6-(8-氨基-1-溴咪唑并[1,5-A]吡嗪-3-基)六氢中氮-3(2H)-酮